Invention Grant
- Patent Title: Trifluoromethyl pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
-
Application No.: US15631380Application Date: 2017-06-23
-
Publication No.: US10085972B2Publication Date: 2018-10-02
- Inventor: Alexander R. Hurd , Clarke B. Taylor , Jian Wang , Peng Zhou
- Applicant: Lycera Corporation
- Applicant Address: US MI Ann Arbor
- Assignee: Lycera Corporation
- Current Assignee: Lycera Corporation
- Current Assignee Address: US MI Ann Arbor
- Agency: Dechert LLP
- Main IPC: A61K31/415
- IPC: A61K31/415 ; C07D231/38 ; A61K9/48 ; A61K9/28 ; A61K9/00
Abstract:
The invention provides trifluoromethyl pyrazolyl guanidine compounds that inhibit F1F0-ATPase, and methods of using trifluoromethyl pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
Public/Granted literature
- US20170354643A1 TRIFLUOROMETHYL PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF Public/Granted day:2017-12-14
Information query
